FY 2026 saw lower revenue but stronger margins, improved cash generation, and a more resilient financial platform. Strategic pivots drove growth in smart infrastructure and medical equipment, with investments in technology and new markets like India. Management remains confident in achieving double…
FY 2026 saw lower revenue but stronger margins, improved cash generation, and a more resilient financial platform. Strategic pivots drove growth in smart infrastructure and medical equipment, with investments in technology and new markets like India. Management remains confident in achieving double-digit EBIT margins and sees further opportunities for profitable growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.